Mitsubishi UFJ Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-57,311
| Closed | -$127K | – | 1635 |
|
|
2025
Q1 | $127K | Buy |
57,311
+4,803
| +9% | +$10.6K | ﹤0.01% | 1003 |
|
|
2024
Q4 | $298K | Buy |
52,508
+28,480
| +119% | +$162K | ﹤0.01% | 930 |
|
|
2024
Q3 | $200K | Sell |
24,028
-2,266
| -9% | -$18.8K | ﹤0.01% | 965 |
|
|
2024
Q2 | $188K | Sell |
26,294
-21,373
| -45% | -$153K | ﹤0.01% | 965 |
|
|
2024
Q1 | $413K | Sell |
47,667
-2,183
| -4% | -$18.9K | ﹤0.01% | 892 |
|
|
2023
Q4 | $316K | Buy |
49,850
+29,231
| +142% | +$185K | ﹤0.01% | 969 |
|
|
2023
Q3 | $206K | Buy |
20,619
+1,170
| +6% | +$11.7K | ﹤0.01% | 1020 |
|
|
2023
Q2 | $242K | Buy |
19,449
+815
| +4% | +$10.1K | ﹤0.01% | 1020 |
|
|
2023
Q1 | $261K | Buy |
18,634
+1,264
| +7% | +$17.7K | ﹤0.01% | 994 |
|
|
2022
Q4 | $238K | Buy |
17,370
+9,765
| +128% | +$134K | ﹤0.01% | 1005 |
|
|
2022
Q3 | $194K | Hold |
7,605
| – | – | ﹤0.01% | 1026 |
|
|
2022
Q2 | $216K | Sell |
7,605
-861
| -10% | -$24.5K | ﹤0.01% | 1037 |
|
|
2022
Q1 | $299K | Buy |
8,466
+914
| +12% | +$32.3K | ﹤0.01% | 1000 |
|
|
2021
Q4 | $300K | Buy |
7,552
+1,761
| +30% | +$70K | ﹤0.01% | 1010 |
|
|
2021
Q3 | $284K | Sell |
5,791
-50
| -0.9% | -$2.45K | ﹤0.01% | 1016 |
|
|
2021
Q2 | $244K | Buy |
+5,841
| New | +$244K | ﹤0.01% | 1069 |
|